|
Dec 1, 2011
By:
William Looney
The gap in perception is one of industry's biggest problems because it adds ballast to the idea that medicines are just a simple procurement item, writes William Looney.
|
Nov 1, 2011
By:
William Looney
If high prices that lower access are attributable to a flawed R&D model, can industry embrace delivering better results at lower costs.
|
|
Oct 1, 2011
By:
William Looney
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
|
Oct 1, 2011
By:
William Looney
Yasuchika Hasegawa, President & CEO, Takeda Pharmaceutical Co.
|
Oct 1, 2011
By:
William Looney
Carlos Morel, MD, Director for Technical Development in Health, Oswaldo Cruz Foundation
|
Oct 1, 2011
By:
William Looney
Peter Piot, MD, Director, London School of Hygiene and Tropical Medicine
|
|
It's a New Day —and a New Script
Oct 1, 2011
By:
William Looney
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen to discuss his agenda for retooling the drug distribution giant.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
